Allergy, immune and surgery care, graded by the evidence.
Plain guides written only from verified research and FDA labels. Every claim shows how strong its evidence is, and every sentence leads to its source.
What brings you here?
Pick the door that fits. Each one opens a library of guides, written in plain language and graded claim by claim.
Allergy and immune care
Food allergy, pollen and mold, cross-reactivity, testing, anaphylaxis, early introduction, immunotherapy, eczema, FPIES, EoE and alpha-gal.
- Anaphylaxis and epinephrine
- Why IgG panels do not diagnose allergy
- Peanut and egg for babies
Getting ready for surgery
Types of anesthesia, fasting, the medicines to bring up, sleep apnea, the drugs you may hear about, and what to expect for common procedures.
- GLP-1 drugs before anesthesia
- TIVA or inhaled anesthesia
- Questions to print
Health Check
A yearly lab panel with a licensed clinician's review and a written plan.
Join the waitlistEvery claim tells you how sure it is
Each sentence carries a grade from the kind of study behind it, from randomized trials to an idea not yet tested. A confident sentence never stands in for strong evidence.
- E1Strong
Randomized trials in people, or reviews that pool them.
- E2Good
Careful observation in people, or a guideline built on the evidence.
- E3Early
Laboratory or animal studies only.
- E4A link, not proof
An association; cause is not shown.
- E5An idea
Proposed, not yet tested.
- Official text
An FDA label or the law, quoted as written.
- Review
An expert review; not graded.
In the LEAP trial, eating peanut from infancy lowered peanut allergy at age 5 from 13.7% to 1.9% in babies at high risk whose first skin test was negative.E1Strong1
Source for the sample
- Randomized trial of peanut consumption in infants at risk for peanut allergy. Du Toit G, N Engl J Med, 2015. E1Strong Randomized trial
The words this page rests on
Among the 530 infants in the intention-to-treat population who initially had negative results on the skin-prick test, the prevalence of peanut allergy at 60 months of age was 13.7% in the avoidance group and 1.9% in the consumption group (P<0.001). Among the 98 participants in the intention-to-treat population who initially had positive test results, the prevalence of peanut allergy was 35.3% in the avoidance group and 10.6% in the consumption group (P=0.004).
Epitope Allergy Care
Allergy care from home: an at-home allergy blood test, a video visit with a licensed clinician who reviews the results, and immunotherapy shipped monthly when it fits.
Para AI
Ask a question about allergy, immune health or getting ready for surgery. Para answers from the verified library and highly cited research, cites every sentence, and checks each one against its source.
Built on a standard, not a sales pitch
Epitope's clinical standards and evidence library are set by Dr. Jesus Recio, a practicing nurse anesthesiologist (CRNA) and doctor of nurse anesthesia practice.
About Epitope Health- Verified, word for word186 sources and 441 excerpts, each checked against PubMed, DailyMed or the original page, and checked again whenever the library changes.
- Honest about what is unknownWhere the research cannot answer a question yet, the guide says so.
- Nothing about you is keptNo accounts, no cookies, no analytics, no trackers. Search runs on your own device.
- Nothing sold that the evidence does not supportNo IgG food panels, mycotoxin panels or wellness peptides. The guides cover them honestly instead.
Looking for an allergist?
A list of allergy and immunology clinicians in Florida, built from the public federal NPI registry. Not a ranking, not an endorsement, and board certification is confirmed at the board's own site.